NASDAQ:PDCO
Delisted

Patterson Companies Stock News

etoro logo Buy PDCO
*Your capital is at risk
$31.33
+0 (+0%)
At Close: Jul 16, 2025

Medtronic (MDT) Obtains U.S. Distribution Rights for BioButton

04:49pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Medtronic's (MDT) new deal with BioIntelliSense will ensure accessibility to BioButton for continuous vital sign measurements of general care patients in the United States.

Boston Scientific (BSX) Grows Operationally Amid Macro Issues

03:04pm, Thursday, 01'st Sep 2022 Zacks Investment Research
In the Asia Pacific region, Boston Scientific (BSX) grows operationally with notable performance in Japan, India and the ASEAN countries.

Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates

02:59pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.
Patterson Companies, Inc. (NASDAQ:PDCO ) Q1 2023 Results Earnings Conference Call September 1, 2022 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Mark Walchirk - Pre
Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.

Patterson Cos. (PDCO) Lags Q1 Earnings and Revenue Estimates

12:15pm, Thursday, 01'st Sep 2022 Zacks Investment Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -15.79% and 2.50%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Patterson Cos. (PDCO) delivered earnings and revenue surprises of -15.79% and 2.50%, respectively, for the quarter ended July 2022.

Henry Schein (HSIC) Inks Deal to Acquire Midway Dental Supply

03:28pm, Wednesday, 31'st Aug 2022 Zacks Investment Research
Henry Schein's (HSIC) acquisition of Midway Dental Supply complements its efforts to offer products and services that deliver more effective, high-quality patient care.

Bruker (BRKR) Debuts Innovations for Proteomics & Metabolomics

05:46pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Bruker's (BRKR) novel nanoElute 2 and next-generation MetaboScape 2023 release are likely to offer enhanced workflows for proteomics and metabolomics applications.

Reasons Why You Should Retain ResMed (RMD) Stock For Now

05:44pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Investors are optimistic about ResMed's (RMD) better-than-expected results and robust device sales.

Haemonetics (HAE) Inks Epic Deal to Expand Hospital Business

03:35pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
According to Haemonetics (HAE), amid the complex situation of blood supply and staffing shortages, the SafeTrace Tx transfusion management system is set to provide more transfusion safety and efficien

Here's Why You Should Hold on to Nevro (NVRO) Stock for Now

12:32pm, Tuesday, 30'th Aug 2022 Zacks Investment Research
Investors continue to be optimistic about Nevro (NVRO), owing to its strength in the global SCS market.

Myriad Genetics (MYGN) Gets Extensive Coverage for BRACAnalysis

04:33pm, Monday, 29'th Aug 2022 Zacks Investment Research
Myriad Genetics' (MYGN) BRACAnalysis gained expanded coverage from MHLW to identify breast cancer patients who are eligible for treatment with Lynparza in Japan.

What's in Store for Patterson Companies (PDCO) in Q1 Earnings?

03:45pm, Monday, 29'th Aug 2022 Zacks Investment Research
Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at the Animal Health segment.

3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio

01:51pm, Monday, 29'th Aug 2022 Zacks Investment Research
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE